MISTIE III: A phase III, randomized, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage
The purpose of this study is to determine the safety and effectiveness of an emergency treatment for intracerebral hemorrhage (spontaneous bleeding in the brain) as compared to current standard of care. The investigational treatment involves a procedure to remove the blood clot in the brain through a small tube, and the use of a drug called rt-PA, to break up the clot and further aid in its removal. Study participants will be randomly assigned to either the investigational treatment or current standard of care, which does not include removal of the clot.
Principal Investigator:
Shakeel Chowdhry, MD
IRB Approval Number:
Funding Source:
Johns Hopkins University/The National Institute of Neurological Disorders and Stroke (NINDS)
Please call 847.570.4224 with questions regarding the study
Open to Enrollment:

Platelet-Oriented Inhibition in New TIA and minor ischemic stroke (POINT) Trial
Aims: To determine whether clopidogrel 75 mg/day by mouth after a loading dose of 600 mg of clopidogrel is effective in preventing major ischemic vascular events (ischemic stroke, myocardial infarction, and ischemic vascular death) at 90 days when initiated within 12 hours of transient ischemic attack (TIA) or minor ischemic stroke onset in patients receiving aspirin 50-325 mg/day (with a dose of 162 mg daily for 5 days followed by 81 mg daily strongly recommended).
Principal Investigator: Rima Dafer, MD, MPH
IRB approval number: EH11-057
Funding source: The National Institute of Neurological Disorders and Stroke (NINDS)
Contact: Please call 847.503.4322 with questions regarding the study
Open to enrollment: Yes

Door-to-Needle Improvement Initiative: Thrombolysis Use in Acute Stroke Consent and Delay
Aims: The purpose of our proposed study is to determine reasons behind delay in administration of intravenous thrombolytic (IV) therapy to patients presenting to one of the four NorthShore emergency departments with symptoms and signs of stroke, and to implement measures to improve early diagnosis and treatment. Our study will attempt to gauge the frequency by which various forms of consent are obtained in the emergent setting with reference to stroke patients. It will also attempt to gauge whether consent delays administration of IV tPA to eligible patients.
Principal Investigator: Fan Caprio, MD
IRB Approval Number: EH15-302
Open to providers only
Contact: Please call 847.503.4322 with questions regarding the study